AC000061_cds3_at 0.68 107m M phase "CTFR; cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7)" -0.366 -1.505 -0.048 0.727 0.863 0.043 1.546 1.045 0.089 -1.004 -1.004 0.317 1.364 AF006084_at 0.41 175g2 G2 phase ARPC1B 1.171 0.067 -0.395 0.254 1.287 1.1 0.104 -0.457 0.077 0.138 0.244 -0.596 -1.048 D13628_at 0.6 381lg1 G1 phase ANGPT1; angiopoietin 1 -0.365 0.968 -0.425 -0.607 -1.515 -0.577 -0.365 0.665 -0.123 0.422 0.089 -0.94 -0.637 D13633_at 0.84 53m M phase KIAA0008; KIAA0008 gene product -0.868 -1.139 -0.054 -0.4 0.021 0.344 -0.625 -0.458 -0.805 -1.399 -0.522 -0.222 0.275 D14678_at 0.89 53m M phase KNSL2; kinesin-like 2 -1.354 -0.151 0.758 -0.397 1.616 1.507 0.501 -0.94 -0.525 -0.407 0.472 0.61 0.58 D14686_at 0.74 175g2 G2 phase AMT; aminomethyltransferase (glycine cleavage system protein T) 1.251 -0.931 0.217 1.599 0.459 0.855 0.071 -1.343 0.629 0.718 1.454 0.031 -0.858 D16217_at 0.67 201g2 G2 phase CAST; calpastatin 1.846 1.028 -0.505 1.345 0.368 -0.677 -1.619 -0.491 -0.292 1.461 0.684 -1.11 -1.385 D16562_at 0.63 368lg1 G1 phase "ATP5C1; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1" 0.142 -0.506 -0.721 -1.583 -0.912 -0.351 0.205 0.547 0.353 -0.653 -0.296 -0.018 0.38 D16593_at 0.65 201g2 G2 phase HPCA1; hippocalcin 1.675 0.926 0.417 2.327 -0.618 -0.033 -0.872 -0.363 1.031 0.626 0.185 -0.43 -0.071 D21063_at 0.77 368lg1 G1 phase MCM2; minichromosome maintenance deficient (S. cerevisiae) 2 (mitotin) 1.022 -0.08 -0.343 -1.105 -1.296 -1.555 0.454 0.171 0.764 0.488 1.323 -0.321 0.107 D23673_at 0.65 107m M phase KIAA0864; KIAA0864 protein -1.309 -0.897 -0.475 -0.503 0.612 -0.412 0.313 0.638 -0.016 -1.414 -0.429 -0.804 0.12 D25278_at 0.54 2g2 G2 phase KIAA0036; KIAA0036 gene product -0.895 1.383 -0.189 -0.525 -0.825 -1.019 -1.778 -0.666 -0.454 -0.012 -0.03 0.571 -0.401 D26018_at 0.93 381lg1 G1 phase "P66; DNA polymerase delta, subunit 3" -0.772 -0.377 -0.212 -0.772 -1.118 -0.773 -0.476 2.424 1.172 -0.014 -0.213 -0.608 -1.02 D26135_at 0.73 53m M phase "DGKG; diacylglycerol kinase, gamma (90kD)" -0.994 -0.442 -0.133 -0.641 0.684 -0.045 -0.243 -0.575 -2.054 -1.788 -0.972 1.081 0.463 D26361_at 0.78 1m M phase KIAA0042; KIAA0042 gene product -0.825 -0.439 -0.278 0.446 1.299 0.72 -1.469 -0.455 -1.694 -0.471 -0.198 -0.294 0.254 D26535_at 0.55 201g2 G2 phase DLST; dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) 0.144 0.156 1.198 -0.077 -1.083 -0.568 -1.083 -0.286 -0.654 0.512 0.671 0.414 -1.169 D28235_at 0.89 2g2 G2 phase PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) -0.788 1.115 0.273 0.135 0.107 -0.594 -0.713 -0.359 -0.217 0.275 -0.517 -0.524 -0.729 D28588_at 0.74 175g2 G2 phase SP2; Sp2 transcription factor -0.464 -0.623 -0.351 0.739 0.648 -0.192 -0.146 -0.895 -0.169 0.489 0.83 -0.782 -0.351 D30037_at 0.71 175g2 G2 phase "PITPNB; phosphotidylinositol transfer protein, beta" -0.432 0.347 0.098 1.522 1.257 0.479 -1.591 -0.151 0.148 0.926 0.843 0.33 -0.598 D31763_at 0.75 368lg1 G1 phase ZNF33A; zinc finger protein 33a (KOX 31) -1.504 -0.397 0.457 -1.315 -0.65 -0.903 -0.049 0.931 0.425 1.848 0.805 -0.556 -0.113 D31764_at 0.56 201g2 G2 phase KIAA0064; KIAA0064 gene product 1.252 -1.842 0.332 0.205 0.598 -0.395 -0.25 -1.715 -0.541 -0.201 0.677 0.75 0.053 D31815_at 0.64 368lg1 G1 phase RGN; regucalcin (senescence marker protein-30) 1.307 0.278 -0.113 0.526 -0.68 -1.284 0.881 1.094 0.846 1.378 -0.006 -0.219 0.526 D31885_at 0.97 53m M phase KIAA0069; KIAA0069 protein -1.188 -1.154 -0.288 -0.514 1.353 0.813 0.12 -0.471 -1.067 -1.271 -0.596 0.068 0.26 D38073_at 0.97 368lg1 G1 phase MCM3; minichromosome maintenance deficient (S. cerevisiae) 3 -0.475 -0.446 -0.1 -1.621 -1.711 -1.07 -0.237 0.757 1.556 1.589 0.581 0.339 0.096 D38503_at 0.68 368lg1 G1 phase PMS2L6; postmeiotic segregation increased 2-like 6 0.752 0.114 0.114 -1.438 -1.347 -0.115 1.483 1.3 0.707 1.026 -0.845 1.255 0.342 D38551_at 0.82 53m M phase RAD21; RAD21 (S. pombe) homolog -1.197 -1.208 -0.5 -0.804 0.698 -0.148 -1.066 -0.655 -1.214 -0.47 -0.178 -0.256 -0.077 D38555_at 0.9 6m M phase "SEC24C; SEC24 (S. cerevisiae) related gene family, member C" 0.946 -0.044 -0.539 -0.652 0.266 0.111 0.101 1.348 0.142 -0.642 -1.137 0.194 0.833 D38751_at 0.69 53m M phase "Human mRNA for Kid (kinesin-like DNA binding protein), complete cds" 0.016 -0.759 -0.315 0.493 1.434 0.686 0.943 -0.672 -0.441 0.069 -0.434 2.46 0.434 D43636_at 0.36 2g2 G2 phase "KIAA0096, KIAA0096 protein" -1.981 -0.024 -0.827 -0.601 0.328 -1.781 -1.83 0.504 -0.048 -0.575 -0.802 -0.049 0.002 D43948_at 0.93 53m M phase KIAA0097; KIAA0097 gene product -1.426 -1.249 -0.462 -0.731 1.758 0.865 -0.32 -1.185 -0.66 -0.617 -0.859 0.149 0.546 D43968_at 0.56 1m M phase RUNX1; runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) -1.027 -0.021 0.636 1.033 0.52 0.335 0.3 -0.849 -0.288 0.027 0.458 -0.836 -0.199 D50370_at 0.69 381lg1 G1 phase NAP1L3; nucleosome assembly protein 1-like 3 1.098 0.482 -0.001 -1.495 -0.968 -0.617 1.713 2.021 -0.177 0.307 -0.616 -0.001 -0.309 D50405_at 0.62 201g2 G2 phase HDAC1; histone deacetylase 1 0.094 0.706 -0.55 -0.157 -0.473 -0.277 -1.019 -1.532 -0.386 0.531 -0.321 -0.179 -0.583 D50925_at 0.65 368lg1 G1 phase KIAA0135; KIAA0135 protein -0.669 0.291 0.467 -0.727 -0.689 -1.589 -0.003 -0.551 0.506 1.916 1.799 -0.512 0.604 D64053_at 0.64 201g2 G2 phase "PTPRR; protein tyrosine phosphatase, receptor type, R" 0.735 0.539 0.145 -0.17 0.027 0.224 -2.177 -1.194 -0.997 1.995 1.011 -0.879 0.106 D64142_at 0.78 1m M phase "H1FX; H1 histone family, member X" -1.316 -0.743 0.371 1.283 0.642 -1.011 -0.464 -1.229 -0.655 -0.03 0.805 0.278 0.314 D78577_at 0.82 1m M phase "YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide" -0.951 -0.378 0.804 0.192 1.017 -0.191 -1.206 -1.196 -0.44 -1.341 -1.065 -0.096 0.433 D79984_at 0.71 2g2 G2 phase SUPT6H; suppressor of Ty (S.cerevisiae) 6 homolog -1.115 0.639 0.808 0.5 0.089 -0.174 -0.56 -0.947 0.173 0.698 -0.397 0.208 0.58 D79989_at 0.59 175g2 G2 phase KIAA0167; KIAA0167 gene product -0.592 -0.382 0.619 0.503 0.759 1.364 1.271 -0.22 -0.988 1.224 1.178 0.479 0.037 D79997_at 0.75 175g2 G2 phase KIAA0175; KIAA0175 gene product -0.668 -1.14 -0.298 -0.107 0.324 -0.087 -1.23 -0.789 -0.548 -0.588 -0.208 -0.228 -0.659 D83920_at 0.41 107m M phase FCN1; ficolin (collagen/fibrinogen domain-containing) 1 -1.035 0.174 -0.084 -0.392 -0.058 0.2 1.743 0.74 -0.418 -0.726 -0.238 0.586 0.688 D84110_at 0.58 287s S phase RBPMS; RNA-binding protein gene with multiple splicing -0.504 0.087 -0.173 -0.859 -0.622 -0.031 -2.017 -1.072 0.395 1.056 0.56 -0.008 -0.457 D84557_at 0.93 368lg1 G1 phase "MCM6; minichromosome maintenance deficient (mis5, S. pombe) 6" 0.052 -1.143 -0.614 -0.979 -1.303 -1.216 -0.459 0.486 1.115 0.618 0.691 -0.231 0.449 D86425_at 0.56 2g2 G2 phase NID2; nidogen 2 -1.296 -0.069 -0.62 -0.306 -0.124 -1.142 -1.686 -0.299 -0.369 -0.584 -0.794 -0.459 -0.125 D86984_at 0.85 287s S phase KIAA0231; KIAA0231 protein -0.297 1.59 0.531 -1.356 -0.397 -1.687 -1.224 -0.926 0.464 1.556 -0.959 -0.198 0.464 D87023_cds2_at 0.75 107m M phase IGL@; immunoglobulin lambda locus -1.239 -0.438 -0.1 0.113 0.964 1.552 0.513 0.501 0.201 -0.563 -0.263 -0.313 0.151 D87076_at 0.77 53m M phase KIAA0239; KIAA0239 protein -0.055 -1.457 -0.435 -0.607 1.76 0.599 0.174 0.14 -0.653 -1.044 -0.711 -0.205 0.186 D87444_at 0.64 175g2 G2 phase KIAA0255; KIAA0255 protein -1.211 -1.046 0.216 0.066 0.464 -0.897 -0.647 -0.034 -0.498 1.144 0.05 -0.183 -0.764 D87449_at 0.72 201g2 G2 phase KIAA0260; KIAA0260 protein 0.388 0.655 0.388 0.201 0.175 0.121 -0.52 -0.973 -0.092 0.708 0.041 -0.199 -0.573 D87953_at 0.42 107m M phase NDRG1; N-myc downstream regulated 1.235 -0.409 -0.445 0.996 1.44 0.809 -0.062 -0.152 -0.702 -0.258 0.267 -0.587 -0.871 D88795_at 0.69 325s S phase "Homo sapiens mRNA for cadherin, partial cds. /gb=D88795 /ntype=RNA" -1.707 -0.595 0.952 -0.188 0.681 -0.595 -1.273 0.057 0.654 2.037 -0.08 -0.188 -0.676 D89289_at 0.58 175g2 G2 phase "FUT8; fucosyltransferase 8 (alpha (1,6) fucosyltransferase)" -1.531 -0.323 -0.154 -0.517 0.886 0.982 -1.918 0.523 1.272 1.369 1.031 -0.081 -0.057 D90209_at 0.74 201g2 G2 phase ATF4; activating transcription factor 4 (tax-responsive enhancer element B67) 2.48 1.344 0.135 2.008 0.792 -0.075 -0.856 -0.975 -0.563 -0.77 -0.32 -0.178 -0.802 HG110-HT110_at 0.65 381lg1 G1 phase -0.941 -0.294 -1.086 -0.575 -0.802 -0.837 -0.837 0.95 -0.082 -0.094 -0.483 -0.062 -0.274 HG2036-HT2090_at 0.59 325s S phase Stimulatory Gdp/Gtp Exchange Protein For C-Ki-Ras P21 And Smg P21 -1.063 0.323 0.475 -0.132 0.8 0.886 -1.279 0.172 0.843 1.146 0.129 -0.435 -0.153 HG2090-HT2152_at 0.7 175g2 G2 phase -0.145 -0.271 -0.321 0.233 0.384 0.711 0.358 -0.321 -0.673 1.364 1.238 1.113 -0.396 HG2239-HT2324_r_at 0.63 381lg1 G1 phase Potassium Channel Protein (Gb:Z11585) -0.988 0.264 -0.227 -0.593 -0.198 -1.068 -1.298 2.356 0.709 1.614 -0.117 0.083 0.799 HG2255-HT2344_f_at 0.55 175g2 G2 phase "Phosphoribosyl Pyrophosphate Synthetase, Subunit Iii" -1.486 0.374 0.838 0.49 1.032 0.858 0.063 -0.731 -0.15 1.768 -0.344 0.257 -0.266 HG2259-HT2348_at 0.71 201g2 G2 phase 1.724 0.461 0.534 1.615 0.653 0.82 -0.522 -0.012 0.352 0.477 0.03 -0.252 -0.319 HG2271-HT2367_at 0.47 201g2 G2 phase 1.676 0.031 -1.046 0.8 0.221 -0.881 -0.147 -0.336 -0.526 0.137 1.049 0.871 0.268 HG2290-HT2386_at 0.72 6m M phase Calcitonin -0.051 -0.51 -0.709 -1.003 0.513 0.49 0.537 0.666 -0.239 -0.592 -0.827 -0.545 0.09 HG2442-HT2538_at 0.57 2g2 G2 phase "Tropomyosin, Alpha, Muscle, Alt. Splice 2, Skeletal Muscle (Fibroblast)" -2.306 0.261 0.123 0.906 0.384 0.445 -0.431 -0.985 -0.216 -0.154 -0.339 -0.708 -0.754 HG2639-HT2735_at 0.7 254s S phase -0.614 0.127 0.651 1.313 0.796 -0.361 -1.411 -1.069 -0.683 -0.047 -1.24 -0.011 -0.661 HG2723-HT2819_at 0.81 175g2 G2 phase Proto-Oncogene N-Cym 0.382 -0.106 -0.655 0.971 1.012 0.402 -0.269 -0.614 0.199 1.479 0.991 0.545 -0.33 HG3313-HT3490_at 0.4 6m M phase "Thyroid Hormone Receptor, Beta-2" -0.319 -0.382 0.187 -2.627 0.25 0.945 0.819 0.092 0.345 -1.583 -0.446 0.693 0.282 HG3344-HT3521_at 0.43 2g2 G2 phase Ubiquitin-Conjugating Enzyme Ubch5 -2.302 0.765 0.872 -0.339 -0.675 -1.724 -0.661 1.424 -0.056 -0.473 -1.455 -0.406 0.657 HG3415-HT3598_at 0.64 254s S phase Poliovirus Receptor -0.396 0.051 1.271 1.276 1.236 0.232 -1.55 -0.752 -0.09 -0.938 0.187 -0.928 -1.234 HG4036-HT4306_at 0.41 201g2 G2 phase Retinoblastoma 1 1.182 0.625 -0.835 1.048 0.01 -0.548 -0.432 -0.221 -0.471 1.22 0.068 -0.759 -0.49 HG4074-HT4344_at 0.64 381lg1 G1 phase "Human peripheral myelin protein-22 (PMP22) gene, non-coding exon 1A. /gb=U08049 /ntype=DNA /annot=exon" 0.442 1.05 -0.379 -0.823 -1.31 -1.063 -0.511 0.536 0.644 -0.413 -0.737 -0.771 -0.316 HG4126-HT4396_at 0.55 107m M phase Zinc Finger Protein Hzf4 -0.352 -1.562 -0.014 -0.239 0.577 0.324 1.563 1.084 1.197 -0.943 -1.45 -0.014 0.549 HG4194-HT4464_at 0.56 201g2 G2 phase Sodium/Hydrogen Exchanger 5 1.178 -0.06 -0.232 1.995 0.849 0.717 -0.983 0.256 -0.061 -0.034 0.322 0.454 0.507 HG4312-HT4582_at 0.83 381lg1 G1 phase -0.609 -0.184 -0.596 -0.916 -0.949 -0.864 -0.42 0.332 -0.395 -0.197 -0.634 -0.732 -0.515 HG4334-HT4604_at 0.71 368lg1 G1 phase 0.542 -0.242 0.004 -0.96 -1.235 -1.223 -0.451 0.016 0.231 -0.056 -0.398 0.225 -0.003 HG4582-HT4987_at 0.61 175g2 G2 phase "Glucocorticoid Receptor, Beta" -1.112 -0.943 -0.436 0.411 -0.387 -0.967 -1.209 -0.363 0.17 1.789 -0.46 -0.75 -1.064 HG4716-HT5158_at 0.55 2g2 G2 phase Guanosine 5'-Monophosphate Synthase -1.785 0.536 0.629 -0.874 -0.641 -0.422 -1.366 -0.497 0.746 -0.054 -0.236 -0.655 -1.083 J02854_at 0.69 201g2 G2 phase "MYRL2; myosin regulatory light chain 2, smooth muscle isoform" 1.697 0.937 0.777 1.604 0.74 -0.083 0.057 -0.153 0.518 0.713 0.109 0.197 -0.105 J02960_cds1_at 0.69 254s S phase "ADRB2; adrenergic, beta-2-, receptor, surface" 0.645 1.265 0.826 1.084 -0.475 -0.278 0.07 0.055 -0.429 0.463 -0.959 -0.717 0.494 J03161_at 0.52 2g2 G2 phase SRF; serum response factor (c-fos serum response element-binding transcription factor) -0.014 -0.238 0.18 2.053 0.015 -0.655 -0.577 0.636 0.627 0.452 0.559 -0.907 -0.024 J03258_at 0.61 325s S phase "VDR; vitamin D (1,25- dihydroxyvitamin D3) receptor" -1.984 0.137 0.753 -0.601 0.322 0.353 -1.984 0.691 0.383 1.398 -0.201 -1.216 -0.201 J03910_rna1_at 0.78 6m M phase MT1G; metallothionein 1G 0.259 -0.654 -0.75 -0.089 0.031 0.571 0.331 0.439 -0.486 -1.014 -0.294 0.295 0.331 J04031_at 0.72 287s S phase "MTHFD1; methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate " -1.032 0.15 1.086 -0.569 -0.909 -1.176 -1.669 -0.94 0.366 0.387 -0.292 -0.138 -0.21 J04088_at 0.74 53m M phase TOP2A; topoisomerase (DNA) II alpha (170kD) -0.223 -0.113 0.045 0.815 2.392 1.142 -0.844 -0.972 -0.402 -0.963 0.627 0.211 -0.313 J04611_at 0.54 201g2 G2 phase G22P1; thyroid autoantigen 70kD (Ku antigen) 0.462 1.041 0.574 -0.789 -0.57 -1.182 -1.03 -1.453 1.263 0.38 0.703 -0.462 -0.069 J05008_at 0.88 254s S phase EDN1; endothelin 1 -0.582 1.601 0.202 1.144 -0.022 -0.61 -0.974 -0.648 -0.535 0.369 -0.76 -0.591 -0.806 J05243_at 0.73 175g2 G2 phase "SPTAN1; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)" -0.801 -0.505 0.776 1.483 1.409 0.331 -0.046 -0.842 0.439 0.789 1.153 -0.787 -0.276 J05614_at 0.62 381lg1 G1 phase "Human proliferating cell nuclear antigen (PCNA) gene, promoter region. /gb=J05614 /ntype=DNA /annot=mRNA" -0.538 0.924 -0.505 -1.366 -1.036 -1.299 -0.778 0.368 0.987 -0.707 -0.505 -0.05 -0.359 K03021_at 0.72 53m M phase "PLAT; plasminogen activator, tissue" -0.746 -0.67 -0.288 0.297 2.165 0.115 -0.487 -0.431 -0.288 -1.178 -0.926 -0.374 -0.581 K03195_at 0.55 201g2 G2 phase "SLC2A1; solute carrier family 2 (facilitated glucose transporter), member 1" 0.606 0.221 0.24 0.967 1.669 1.094 -1.051 -1.216 -0.9 0.126 -0.412 -1.513 -1.191 L07541_at 0.71 381lg1 G1 phase RFC3; replication factor C (activator 1) 3 (38kD) 0.104 0.535 -0.635 -1.713 -0.328 -0.42 0.781 0.412 0.75 -0.02 -0.512 -0.851 -1.251 L08246_at 0.68 2g2 G2 phase MCL1; myeloid cell leukemia sequence 1 (BCL2-related) -0.995 1.311 -0.124 0.889 1.676 0.033 -1.033 -0.972 -0.496 -0.333 -0.147 -0.774 -0.877 L11353_at 0.63 53m M phase NF2; neurofibromin 2 (bilateral acoustic neuroma) -1.823 -0.472 -0.451 0.493 1.243 -0.301 1.436 0.278 -0.987 -0.579 -0.73 -0.001 0.536 L12723_at 0.68 201g2 G2 phase HSPA4; heat shock 70kD protein 4 0.386 0.129 -0.113 -0.008 0.025 0.282 -0.933 -0.973 0.748 0.273 1.118 0.78 -0.097 L19527_at 0.55 381lg1 G1 phase RPL27; ribosomal protein L27 1.272 0.576 -1.212 -1.068 0.435 -0.608 1.09 1.057 0.739 1.004 -0.196 0.692 -0.252 L19871_at 0.71 254s S phase ATF3; activating transcription factor 3 -0.355 2.073 -0.043 -0.369 -0.192 -0.436 -0.626 -0.436 -0.328 0.296 -0.423 -0.531 -0.572 L22005_at 0.6 53m M phase CDC34; cell division cycle 34 0.073 -0.664 -0.543 -0.185 1.974 -0.128 -0.657 0.28 -0.557 -0.9 -0.493 -0.049 -0.178 L22206_at 0.7 2g2 G2 phase AVPR2; arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) -0.76 0.431 0.513 0.878 1.057 -0.246 -0.522 -0.336 0.208 0.58 -0.15 -0.314 0.923 L26336_at 0.64 201g2 G2 phase HSPA2; heat shock 70kD protein 2 0.398 -0.599 -0.064 -0.027 0.324 0.804 -1.337 -1.337 -0.248 0.213 -0.082 -0.008 0.417 L26953_at 0.55 6m M phase RMSA1; regulator of mitotic spindle assembly 1 0.004 0.163 -1.146 -1.582 0.242 0.956 1.986 0.361 -0.71 -1.661 0.361 0.837 0.282 L28010_at 0.67 381lg1 G1 phase HNRPF; heterogeneous nuclear ribonucleoprotein F 0.182 -0.312 -0.609 -1.29 -0.968 -0.949 -0.312 0.622 0.752 -1.203 -0.288 -0.251 -0.133 L35240_at 0.76 1m M phase ENIGMA; enigma (LIM domain protein) -0.588 0.668 0.835 0.885 1.462 0.771 -0.126 -0.684 -0.773 -0.097 1.027 -0.325 0.291 L37033_at 0.72 1m M phase FKBP8; FK506-binding protein 8 (38kD) 0.146 -0.93 1.167 0.009 0.105 0.337 -0.582 -1.517 -0.464 -0.371 0.972 0.385 0.628 L37368_at 0.55 6m M phase "Human (clone E5.1) RNA-binding protein mRNA, complete cds" 0.183 -0.568 -1.257 -0.365 0.979 0.661 0.802 0.29 -0.453 -1.513 0.572 0.696 -0.4 L38487_at 0.69 201g2 G2 phase ESRRA; estrogen-related receptor alpha 0.006 -0.235 0.073 0.495 -0.466 0.81 -2.875 -1.683 0.629 1.038 0.941 0.663 -0.168 L38503_at 0.74 201g2 G2 phase GSTT2; glutathione S-transferase theta 2 0.926 0.181 -0.069 1.106 0.655 0.79 -1.378 -0.407 -0.272 0.293 0.745 -0.904 -0.723 L38929_at 0.48 381lg1 G1 phase "PTPRD; protein tyrosine phosphatase, receptor type, D " -2.748 0.933 -0.572 -0.508 -0.764 -0.572 0.133 2.181 0.069 1.477 0.133 0.229 0.165 L39009_at 0.67 107m M phase "Homo sapiens class IV alcohol dehydrogenase 7 (ADH7) gene, 5' flanking region. /gb=L39009 /ntype=DNA /annot=mRNA" -1.739 0.959 -0.121 0.419 1.074 0.458 1.19 0.497 0.034 -1.199 -1.045 -0.236 0.843 L39211_at 0.77 325s S phase "CPT1A; carnitine palmitoyltransferase I, liver" -1.179 0.28 0.815 0.523 0.572 0.864 -0.595 -0.304 0.134 0.961 0.766 0.378 0.912 L40357_at 0.62 201g2 G2 phase TRIP7; thyroid hormone receptor interactor 7 0.036 0.997 0.208 0.058 0.57 -0.519 -1.287 -0.391 0.506 0.378 0.741 0.272 -0.241 L41919_rna1_at 0.54 107m M phase HIC1; hypermethylated in cancer 1 -0.446 0.956 -0.187 1.483 1.109 0.505 1.013 -0.494 -0.821 -0.638 0.312 -0.389 -0.005 L42452_at 0.76 287s S phase RALBP1; ralA binding protein 1 -1.211 -0.099 1.27 -0.741 0.094 -1.296 -1.211 0.735 0.713 1.397 -0.912 0.542 0.585 L42563_at 0.66 175g2 G2 phase "ATPAL1; ATPase, Na+/K+ transporting, alpha polypeptide-like 1" 0.008 -0.096 -0.365 1.045 0.838 1.212 -1.153 -0.345 0.257 0.713 0.817 -1.278 0.05 L42572_at 0.58 368lg1 G1 phase "IMMT; inner membrane protein, mitochondrial (mitofilin) " -0.593 -0.158 -0.05 -0.947 -1.15 -1.639 -0.892 -0.919 -0.009 -0.104 0.29 -0.267 -0.321 L43821_at 0.83 2g2 G2 phase HEF1; enhancer of filamentation 1 (cas-like docking; Crk-associated substrate related) -1.694 1.78 0.498 0.397 0.987 -1.965 -0.986 -0.497 0.414 0.228 -1.223 -0.177 -0.278 L47276_at 0.9 1m M phase -0.535 -0.704 0.774 0 1.235 0.443 -1.766 -1.274 -1.031 -0.631 -0.278 0.604 0.166 L76517_at 0.84 53m M phase PSEN1; presenilin 1 (Alzheimer disease 3) -0.626 -0.947 0.452 0.481 1.049 2.229 0.423 -0.16 -0.932 0.073 0.671 0.292 0.394 M10050_at 0.52 107m M phase "FABP2; fatty acid binding protein 2, intestinal" -0.434 -0.8 -0.891 -0.434 0.389 -0.617 0.053 0.358 0.511 -1.896 -0.8 0.846 -0.343 M10058_at 0.63 1m M phase ASGR1; asialoglycoprotein receptor 1 0.386 0.334 0.562 1.123 0.325 1.07 0 -0.544 -0.342 0.228 0.649 -0.088 0.404 M12174_at 0.9 2g2 G2 phase "ARHB; ras homolog gene family, member B" -0.478 1.788 0.669 1.838 0.543 -0.55 -0.369 -0.703 -0.468 1.094 0.483 -0.588 -0.785 M13150_at 0.53 6m M phase MAS1; MAS1 oncogene 1.079 -0.249 0.027 -0.299 -0.825 0.679 1.079 0.804 0.303 -0.199 -0.124 -0.625 1.154 M13194_at 0.48 201g2 G2 phase "ERCC1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)" 1.523 0.03 -0.082 1.748 0.833 0.847 0.483 -0.266 0.196 0.295 0.505 -0.378 -0.755 M14758_at 0.62 287s S phase "ABCB1; ATP-binding cassette, sub-family B (MDR/TAP), member 1" -1.282 -0.429 0.14 -0.51 -0.47 -0.469 -1.444 0.424 1.439 1.48 -1.16 -0.673 -0.795 M15958_at 0.53 175g2 G2 phase GAS; gastrin -1.086 0.072 0.048 1.158 0.337 0.555 -0.555 -0.326 1.29 0.313 1.037 0.567 0.313 M18700_at 0.64 175g2 G2 phase "ELA3; elastase 3, pancreatic (protease E) " -0.194 0.132 -0.604 1.252 0.903 0.156 -0.58 -0.254 -0.7 2.12 1.023 0.722 0.686 M19311_at 0.93 107m M phase "CALM2; calmodulin 2 (phosphorylase kinase, delta)" -1.531 -0.135 0.128 0.993 0.595 1.184 0.775 1.16 -1.05 -1.992 -1.002 0.213 0.069 M19645_at 0.74 381lg1 G1 phase "HSPA5; heat shock 70kD protein 5 (glucose-regulated protein, 78kD)" 0.166 -0.247 -1.309 -1.03 -0.198 -0.353 0.189 0.497 1.004 0.295 -0.723 -0.318 -1.332 M19650_at 0.67 2g2 G2 phase "CNP; 2',3'-cyclic nucleotide 3' phosphodiesterase" -0.549 0.523 0.592 -0.082 0.512 -0.584 -0.777 -0.8 0.603 0.956 0.193 0.112 0.272 M19989_cds1_at 0.61 201g2 G2 phase PDGFA; platelet-derived growth factor alpha polypeptide 1.07 0.307 0.231 1.027 0.296 0.831 0.154 -0.467 1.005 0.983 0.656 0.809 -0.25 M21574_at 0.77 1m M phase "PDGFRA; platelet-derived growth factor receptor, alpha polypeptide" -1.319 -1.006 0.054 -0.2 -0.424 -0.446 -1.304 -0.909 -0.775 -0.946 0.286 0.688 0.703 M21624_at 0.7 368lg1 G1 phase TRD@; T cell receptor delta locus 0.466 -0.07 0.437 -0.784 -0.636 -1.231 0.407 1.211 0.199 0.585 1.538 0.437 0.139 M21984_at 0.59 254s S phase "TNNT3; troponin T3, skeletal, fast" 0.196 -0.107 1.492 0.707 -0.662 -0.426 -0.544 -0.421 0.107 -0.039 0.488 -0.981 0.163 M22612_f_at 0.73 175g2 G2 phase "PRSS1; protease, serine, 1 (trypsin 1)" 0.983 -1.053 0.678 -0.069 0.627 1.492 -0.204 -0.663 -0.289 0.848 1.034 -0.646 -0.781 M22919_rna2_at 0.53 254s S phase "MYL8; myosin, light polypeptide 6, alkali, smooth muscle and non-muscle" 0.473 0.562 0.482 0.749 1.104 0.295 -0.043 0.064 0.544 0.295 0.064 -0.799 -1.697 M23323_at 0.56 287s S phase "CD3E; CD3E antigen, epsilon polypeptide (TiT3 complex)" 0.921 0.566 1.048 0.948 -0.927 -0.745 -0.444 0.448 0.166 1.157 1.312 0.411 0.293 M23379_at 0.83 53m M phase RASA1; RAS p21 protein activator (GTPase activating protein) 1 -0.551 -1.462 0.086 0.704 1.032 0.771 -0.825 -1.035 -0.968 -1.608 -0.924 0.016 -0.08 M24485_at 0.43 368lg1 G1 phase GSTP1; glutathione S-transferase pi 1.122 -0.13 0.686 -0.649 -0.525 0.804 0.31 0.764 0.27 0.156 0.22 0.951 0.956 M25753_at 0.93 53m M phase CCNB1; cyclin B1 -1.557 -1.34 -0.386 -0.39 0.755 1.442 0.499 -0.695 -0.939 -0.933 -0.399 0.149 0.711 M27436_at 0.93 254s S phase "F3; coagulation factor III (thromboplastin, tissue factor)" -0.781 1.275 0.939 0.51 -0.202 -0.788 -1.183 -0.386 -0.241 0.367 -0.562 -0.388 -0.807 M30448_at 0.81 368lg1 G1 phase "CSNK2B; casein kinase 2, beta polypeptide" -0.55 0.08 -0.41 -0.642 -0.762 -0.691 0.312 0.432 0.511 0.337 0.324 0.349 0.171 M31423_at 0.52 53m M phase CDR1; cerebellar degeneration-related protein (34kD) 0.098 -1.994 0.553 -0.13 0.78 0.507 0.734 0.143 0.643 -0.63 -1.449 0.143 1.28 M31551_at 0.7 107m M phase "PAI2; plasminogen activator inhibitor, type II (arginine-serpin)" -1.008 -0.541 -0.449 -0.088 0.677 -0.031 -0.371 0.005 -0.3 -0.441 -0.661 -0.604 -0.548 M31682_at 0.81 107m M phase "INHBB; inhibin, beta B (activin AB beta polypeptide)" -1.691 -1.075 -0.258 0.659 1.333 1.032 1.347 0.917 -0.244 -0.717 -0.96 0.473 -0.616 M32304_at 0.67 201g2 G2 phase TIMP2; tissue inhibitor of metalloproteinase 2 0.985 0.457 0.813 0.46 0.578 1.051 -1.247 -0.731 0.832 0.613 -0.131 -0.885 -0.793 M33493_at 0.66 6m M phase "TPS2; tryptase, beta (tryptase II)" 1.972 0.609 0.728 -0.666 -0.132 1.498 1.024 0.624 0.016 -0.132 -0.474 0.564 0.609 M36430_at 0.58 325s S phase ARF1; ADP-ribosylation factor 1 -0.544 0.288 0.375 0.696 0.615 0.521 -0.282 -0.277 1.151 0.424 1.041 0.074 0.359 M37763_at 0.51 287s S phase NTF3; neutrophin 3 -0.911 0.971 0.016 0.644 -0.694 -0.257 -0.748 -0.039 0.589 1.98 1.435 0.044 -0.366 M55153_at 0.6 325s S phase "TGM2; transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) " -1.693 0.369 0.661 -0.087 2.102 -0.155 -1.29 0.302 -0.065 -0.109 -0.05 -0.677 -0.012 M55268_at 0.58 6m M phase "CSNK2A2; casein kinase 2, alpha prime polypeptide" -0.135 -0.824 -1.673 -0.28 0.118 0.29 1.244 1.391 0.343 -0.347 -0.732 -0.851 0.595 M55671_at 0.7 368lg1 G1 phase "PROZ; protein Z, vitamin K-dependent plasma glycoprotein " -0.089 -0.256 -0.644 -1.221 -1.277 -0.4 2.309 1.576 1.454 0.411 -0.056 -0.478 0.744 M57763_at 0.67 201g2 G2 phase ARF6; ADP-ribosylation factor 6 0.629 0.864 0.589 0.031 0.844 0.727 -1.173 -1.34 -0.008 0.863 -0.184 -0.723 -0.909 M60278_at 0.82 254s S phase DTR; diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) -0.246 2.415 0.635 0.252 -0.18 -0.027 -0.312 -0.384 -0.548 -0.144 -0.099 -0.528 -0.414 M60748_at 0.72 287s S phase "H1F4; H1 histone family, member 4 " 0.98 0.59 0.16 0.687 -1.597 -0.601 -0.699 -0.719 0.414 2.268 0.121 0.141 -0.289 M60974_at 0.83 254s S phase "GADD45A; growth arrest and DNA-damage-inducible, alpha" 0.497 1.333 0.361 0.554 -0.524 -1.065 -0.909 -0.726 -0.05 0.358 -0.272 -0.382 -0.73 M61916_at 0.69 287s S phase "LAMB1; laminin, beta 1" -0.345 -0.478 0.214 -0.345 -0.201 -0.123 -0.526 -0.321 -0.364 0.641 -0.081 -0.34 -0.37 M62994_at 0.59 107m M phase "FLNB; filamin B, beta (actin-binding protein-278)" 0.402 -0.987 -0.97 1.769 1.849 0.841 0.486 -0.02 -0.215 -0.012 -0.063 -0.223 -0.768 M63838_at 0.87 368lg1 G1 phase "IFI16; interferon, gamma-inducible protein 16" 0.173 -0.224 -0.148 -0.886 -1.245 -1.056 -0.205 0.419 0.457 0.325 0.268 0.477 0.211 M63904_at 0.54 53m M phase "GNA15; guanine nucleotide binding protein (G protein), alpha 15 (Gq class)" -1.178 -0.804 -0.381 -0.202 0.009 0.871 1.814 0.205 -1.487 -0.267 -1.275 0.627 0.237 M69066_at 0.93 107m M phase MSN; moesin 0.304 -0.42 -0.099 1.293 1.367 1.085 0.394 1.201 0.315 -1.732 -1.163 -0.219 0.019 M76766_at 0.54 287s S phase GTF2B; general transcription factor IIB -0.897 1.338 -0.275 -0.403 -0.751 0.001 -1.923 -0.733 0.715 1.264 0.495 -1.062 -0.495 M77836_at 0.77 6m M phase PYCR1; pyrroline-5-carboxylate reductase 1 2.321 -0.417 -1.139 1.246 0.722 0.22 1.305 1.551 -0.219 -0.288 -0.353 -0.193 0.3 M80899_at 0.89 175g2 G2 phase AHNAK; AHNAK nucleoprotein (desmoyokin) 0.317 -1.052 0.164 0.711 0.864 1.367 -0.392 -0.101 0.599 1.528 0.519 1.03 0.129 M81933_at 0.45 107m M phase CDC25A; cell division cycle 25A -0.266 2.034 0.522 0.759 0.009 0.859 1.309 0.822 0.434 -0.691 -0.991 -0.066 -0.504 M86699_at 0.82 53m M phase TTK; TTK protein kinase -0.641 -1.134 0.065 -0.344 1.265 0.409 -1.125 -1.385 -0.948 -0.734 0.028 0.382 -0.428 M87339_at 0.57 381lg1 G1 phase RFC4;.35120 replication factor C (activator 1) 4 (37kD) 1.345 -0.714 -0.534 -0.311 -1.031 -0.74 -0.371 0.701 1.036 -0.525 -0.92 -0.337 0.195 M90657_at 0.71 53m M phase TMF4SF1; transmembrane 4 superfamily member 1 -0.131 -0.613 0.173 1.085 2.032 2.083 -0.831 -0.583 -0.254 -0.192 -0.005 -0.456 -0.208 M91029_cds2_at 0.64 381lg1 G1 phase AMPD2; adenosine monophosphate deaminase 2 (isoform L) 0.668 0.527 -0.603 -1.36 0.235 0.033 1.738 2.122 -0.038 0.931 0.073 -0.603 -0.21 M91467_at 0.65 325s S phase HTR1E; 5-hydroxytryptamine (serotonin) receptor 1E 0.541 0.207 0.385 0.497 0.385 0.34 -2.182 -0.486 -0.441 1.925 1.702 -0.218 0.385 M91670_at 0.83 53m M phase E2-EPF; ubiquitin carrier protein -0.754 -0.946 -0.473 -0.033 1.375 1.598 1.292 0.099 -0.391 0.024 -0.118 0.335 0.47 M92843_at 0.77 2g2 G2 phase ZFP36; zinc finger protein homologous to Zfp-36 in mouse -0.173 0.256 0.722 0.526 -0.516 -1.129 -1.643 -0.455 -0.479 0.44 -0.271 -0.626 0.073 M92934_at 0.87 2g2 G2 phase CTGF; connective tissue growth factor -0.455 1.367 1.074 2.053 1.162 -0.053 -0.649 -0.545 -0.324 0.747 0.092 -0.469 -0.879 M94167_at 0.66 201g2 G2 phase NRG1; neuregulin 1 1.501 0.206 0.587 1.984 -0.112 -0.86 -0.558 -0.587 0.746 0.58 0.033 0.249 0.011 M94345_at 0.41 53m M phase "CAPG; capping protein (actin filament), gelsolin-like " 0.587 0.559 0.503 0.652 1.571 0.708 0.679 -0.389 -0.342 0.457 0.262 -0.277 -0.138 M94630_at 0.69 368lg1 G1 phase HNRPD; heterogeneous nuclear ribonucleoprotein D -1.148 0.225 -0.182 -1.048 -0.062 -1.69 -0.489 -0.028 1.334 1.621 1.309 0.598 0.597 M95178_at 0.87 175g2 G2 phase "ACTN1; actinin, alpha 1" -0.208 -0.11 0.343 0.854 0.893 0.908 0.317 -0.234 0.47 1.242 1.05 -0.155 -0.429 M97675_at 0.93 287s S phase ROR1; receptor tyrosine kinase-like orphan receptor 1 -0.135 0.38 0.76 -0.217 -0.271 -0.786 -0.623 -0.515 -0.217 1.6 -0.027 -0.271 0.353 M99439_at 0.85 368lg1 G1 phase "TLE4; transducin-like enhancer of split 4, homolog of Drosophila E(sp1)" 0.634 -0.922 -0.63 -0.023 -0.808 -0.573 0.077 1.056 1.441 1.705 1.741 0.163 1.034 S57212_at 0.6 325s S phase "MEF2C; MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)" 0.306 0.307 1.307 0.815 -0.12 -1.186 -0.907 0.635 0.159 0.963 1.931 -0.35 0.257 S67325_at 0.88 287s S phase "PCCB; propionyl Coenzyme A carboxylase, beta polypeptide" 0.396 0.794 0.397 -1.337 -1.167 -1.11 -0.172 -0.626 -0.399 2.499 -1.053 -0.257 0.112 S81914_at 0.81 254s S phase IER3; immediate early response 3 -0.336 2.935 0.512 0.215 -0.002 -0.34 -0.258 -0.447 -0.638 0.001 -0.733 -0.687 -0.732 S82240_at 0.69 201g2 G2 phase "ARHE; ras homolog gene family, member E" 0.323 0.168 0.184 0.446 0.674 -0.216 -0.983 -0.028 0.119 0.078 0.364 -0.371 -0.51 S83325_at 0.54 2g2 G2 phase ASPH; aspartate beta-hydroxylase -1.363 0.365 1.25 0.645 -0.694 -0.457 0.278 0.063 0.537 1.013 0.753 0.43 -0.672 S83366_cds1_at 0.64 201g2 G2 phase 0.894 0.375 1.196 0.678 -0.122 -0.359 -0.143 -0.597 0.354 1.326 1.585 -0.36 -0.273 S83366_cds3_at 0.44 6m M phase Region centromeric to t(12;17) 0.504 0.504 0.906 -1.547 -0.22 -0.421 2.595 1.429 -0.3 -0.3 -0.984 0.303 0.062 S94421_at 0.55 175g2 G2 phase "TCR eta =T cell receptor eta-exon [human, Genomic, 806 nt]" 0.235 -1.127 0.586 0.836 -0.333 -0.253 -0.355 0.065 0.485 0.461 0.518 -0.684 -0.594 U00802_at 0.84 107m M phase DBN1; drebin 1 -0.76 -1.681 -0.187 0.534 0.953 0.493 0.843 0.602 -0.091 -1.417 -0.556 0.128 0.251 U01038_at 0.97 53m M phase PLK; polo (Drosophia)-like kinase -1.172 -1.408 -0.142 0.001 1.358 1.668 0.232 -0.841 -1.094 -0.889 0.297 0.56 0.668 U02493_at 0.81 287s S phase NONO; non-Pou domain-containing octamer (ATGCAAAT) binding protein -0.307 0.635 0.256 -0.746 -0.412 -1.475 -0.909 -0.241 0.043 0.782 -0.045 0.223 0.51 U04636_rna1_at 0.97 254s S phase PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) -0.379 1.319 1.03 1.005 0.071 -0.573 -0.788 -0.354 -0.401 0.349 -0.374 -0.635 -0.891 U04806_at 0.77 107m M phase FLT3LG; fms-related tyrosine kinase 3 ligand -1.039 -0.607 -0.39 0.129 -0.361 0.331 0.461 0.763 -0.534 -1.01 -0.765 -0.592 0.317 U04810_at 0.9 53m M phase TROAP; trophinin associated protein (tastin) -0.768 -1.526 0.213 0.272 1.846 0.245 -0.121 -1.213 -0.635 -1.52 0.155 0.495 0.235 U05340_at 0.91 53m M phase "CDC20; cell division cycle 20, S.cerevisiae homolog " -1.366 -1.418 -0.427 0.327 1.444 1.999 1.198 -0.163 -0.79 -0.472 -0.001 0.441 0.829 U08049_at 0.66 201g2 G2 phase 1.473 0.984 0.726 -0.46 -0.563 -0.047 -1.052 -0.769 0.288 0.288 -0.228 -1.13 -0.666 U09279_at 0.56 107m M phase "COL19A1; collagen, type XIX, alpha 1" -2.256 0.13 0.168 -0.487 0.322 0.976 2.053 0.668 0.13 -1.948 -0.64 1.13 1.091 U09579_at 0.68 201g2 G2 phase "CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1)" 3.199 2.067 0.843 0.77 -0.445 -1.04 -0.606 -0.646 -0.592 0.001 0.127 -0.678 -0.805 U09820_at 0.73 287s S phase ATRX; alpha thalassemia/mental retardation syndrome X-linked 0.392 -0.315 1.046 -0.943 -0.472 -0.106 -0.027 -0.236 -0.027 1.753 -0.237 -0.629 -0.551 U09937_rna1_at 0.58 175g2 G2 phase "PLAUR; plasminogen activator, urokinase receptor" -0.223 -0.095 0.494 2.038 1.111 2.031 0.13 -0.26 -0.27 0.595 -0.308 -0.291 -0.835 U10362_at 0.58 6m M phase GP36B; endoplasmic reticulum glycoprotein 1.313 -1.584 0.435 -0.211 1.321 0.754 0.563 -0.052 0.356 -1.528 -1.001 -0.179 0.826 U13737_at 0.6 175g2 G2 phase "CASP3; caspase 3, apoptosis-related cysteine protease" 0.437 0.333 0.295 1.296 0.465 1.051 0.002 -0.688 0.805 0.512 0.494 -0.178 -0.159 U14187_at 0.75 201g2 G2 phase EFNA3; ephrin-A3 2.661 0.295 0.407 1.262 -0.439 -1.069 -1.156 -0.897 0.675 1.357 0.537 0.235 -0.18 U14383_at 0.73 287s S phase "MUC8; mucin 8, tracheobronchial" 0.285 0.125 1.017 0.359 -0.329 -0.446 -1.529 0.783 0.549 1.368 0.71 -0.373 1.002 U14391_at 0.77 325s S phase MYO1C; myosin IC -0.538 0.522 1.13 0.6 0.679 -0.067 -0.577 -0.244 -0.44 0.404 0.326 -0.479 0.561 U14518_at 0.91 53m M phase CENPA; centromere protein A (17kD) -2.108 -1.284 -0.174 0.352 1.615 0.622 -0.882 -0.985 -1.327 -0.619 -0.043 0.586 -0.138 U15932_at 0.94 254s S phase DUSP5; dual specificity phosphatase 5 -0.327 0.896 1.263 0.167 0.228 -0.181 -0.816 -0.614 -0.487 -0.186 -0.309 -0.638 -0.84 U17163_at 0.55 6m M phase ETV1; ets variant gene 1 2.675 0.215 -0.164 -0.138 -1.328 0.052 0.728 0.728 0.052 -1.381 1.107 -0.111 0.783 U18018_at 0.81 107m M phase "ETV4; ets variant gene 4 (E1A enhancer-binding protein, E1AF)" -0.783 -1.231 -0.222 -0.441 1.727 0.35 0.06 0.7 -0.353 -1.643 -1.249 -0.028 -0.318 U18543_at 0.77 201g2 G2 phase "HT2A; TAT-INTERACTIVE PROTEIN, 72-KD" 1.536 0.512 0.789 1.216 0.501 0.533 -0.492 0.01 0.65 1.259 1.077 -0.044 -0.663 U19495_at 0.81 368lg1 G1 phase SDF1; stromal cell-derived factor 1 0.048 -0.614 0.232 -0.507 -1.145 -0.926 -0.181 -0.01 0.36 0.65 -0.475 0.176 0.512 U19948_at 0.67 175g2 G2 phase PDI; protein disulfide isomerase 0.801 -0.719 0.119 2.357 0.215 1.005 0.562 -0.839 0.274 0.945 1.244 0.119 0.239 U20647_at 0.63 201g2 G2 phase ZNF151; zinc finger protein 151 (pHZ-67) 2.369 0.017 0.202 0.99 -0.32 -0.111 -0.412 -0.563 0.596 1.21 0.666 -1.13 -0.586 U20734_at 0.72 254s S phase JUNB; jun B proto-oncogene -0.566 3.329 0.575 -0.347 -0.333 -0.472 -0.444 -0.288 -0.404 0.096 -0.341 -0.311 -0.349 U20980_at 0.84 381lg1 G1 phase "CHAF1B; chromatin assembly factor 1, subunit B (p60)" 0.182 -0.814 0.333 -0.401 -1.19 -0.288 -0.081 1.311 0.709 1.273 -0.814 -0.871 -0.701 U22376_cds2_at 0.84 6m M phase MYB; v-myb avian myeloblastosis viral oncogene homolog 0.88 0.067 -0.581 -1.062 0.895 0.504 0.368 0.459 -0.28 -1.74 -1.936 0.579 1.091 U23430_at 0.72 201g2 G2 phase CCKAR; cholecystokinin A receptor 2.197 0.228 0.461 1.312 -0.292 -0.59 -1.121 -0.314 0.007 1.555 0.704 0.04 0.228 U23736_at 0.7 107m M phase "PRDM2; PR domain containing 2, with ZNF domain" -0.748 -0.119 0.411 1.107 0.544 1.736 1.901 0.213 0.312 -0.417 -1.311 -0.119 0.842 U24152_at 0.53 6m M phase PAK1; p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related) 1.98 0.546 0.861 -0.671 -0.985 1.43 0.566 0.645 -0.298 -0.141 -0.691 0.232 0.134 U24183_at 0.77 368lg1 G1 phase "PFKM; phosphofructokinase, muscle" -1.133 -0.41 -0.038 -1.051 -1.483 -0.667 1.314 1.291 0.779 0.685 0.86 0.778 1.163 U25988_at 0.58 107m M phase PSG11; pregnancy specific beta-1-glycoprotein 11 0.163 0.257 0.796 1.488 0.328 1.374 -0.396 -0.066 -0.125 -0.97 0.352 0.67 -0.471 U25997_at 0.62 107m M phase STC1; stanniocalcin -1.012 -0.192 -0.284 -0.422 1.392 -0.145 -0.388 0.086 -0.631 -0.642 -1.151 -0.515 -0.538 U27516_at 0.68 325s S phase RAD52; RAD52 (S. cerevisiae) homolog -0.751 -1.631 0.534 -0.465 0.748 -0.037 -1.654 -0.87 0.938 0.819 -0.109 -0.133 0.962 U27655_at 0.57 254s S phase RGS3; regulator of G-protein signalling 3 0.685 1.215 0.013 1.932 1.28 0.757 -0.26 -0.697 -0.403 1.115 -0.117 -0.353 -0.583 U27768_at 0.89 201g2 G2 phase RGS4; regulator of G-protein signalling 4 1.164 0.484 0.928 1.646 0.851 0.178 -1.62 -0.756 -0.098 0.216 1.241 -0.297 -1.001 U28386_at 0.97 53m M phase "KPNA2; karyopherin alpha 2 (RAG cohort 1, importin alpha 1)" -1.396 -1.336 -0.363 0.125 1.332 1.022 -0.244 -0.797 -1.272 -1.653 -0.851 0.325 0.239 U28413_at 0.67 325s S phase CKN1; Cockayne syndrome 1 (classical) -0.086 0.175 0.533 1.022 1.249 -1.486 -1.714 -0.184 0.826 0.5 0.533 0.045 0.631 U28749_at 0.81 53m M phase HMGIC; high-mobility group (nonhistone chromosomal) protein isoform I-C -1.531 -0.985 -0.172 -0.331 0.88 0.05 -0.735 -0.124 -0.479 -1.007 -0.954 -0.095 -0.439 U29343_at 0.66 53m M phase HMMR; hyaluronan-mediated motility receptor (RHAMM) -1.822 -1.388 -0.702 -0.834 0.455 -0.268 0.081 0.31 -0.377 -0.617 -0.425 0.346 0.057 U29463_at 0.63 201g2 G2 phase CYB561; cytochrome b-561 1.485 0.785 0.177 -0.615 -0.614 -0.432 -0.858 -0.356 0.025 0.055 0.025 -0.356 -0.371 U29615_at 0.77 107m M phase CHIT1; chitinase 1 (chitotriosidase) -1.19 -0.729 -1.236 0.169 0.515 0.135 0.077 1.828 0.077 -1.95 -0.591 -0.407 0.515 U31929_at 0.76 287s S phase "NR0B1; nuclear receptor subfamily 0, group B, member 1" -0.075 0.048 1.25 -0.476 -0.969 -0.26 -1.369 0.757 -0.322 2.02 0.418 -1.431 0.634 U32114_at 0.92 201g2 G2 phase "Human caveolin-2 mRNA, complete cds" 1.021 -0.447 0.48 0.578 -0.16 -0.206 -1.11 -1.68 -0.667 -0.108 0.515 0.071 -1.121 U33053_at 0.79 201g2 G2 phase PRKCL1; protein kinase C-like 1 1.159 0.483 0.151 1.297 0.786 0.427 -0.733 -0.105 -0.14 -0.36 1.097 0.538 0.317 U33203_at 0.93 287s S phase "MDM2; mouse double minute 2, human homolog of; p53-binding protein" 0.11 0.343 0.731 -0.472 0.071 -1.598 -2.14 0.071 -0.162 1.972 -1.132 0.382 0.498 U33286_at 0.69 201g2 G2 phase CSE1L; chromosome segregation 1 (yeast homolog)-like 0.223 0.752 0.309 -0.493 -0.36 -0.686 -0.803 -1.807 -0.178 0.244 -0.05 0.218 -0.584 U33761_at 0.63 381lg1 G1 phase SKP2; S-phase kinase-associated protein 2 (p45) 0.325 1.347 0.729 -0.455 -0.723 0.03 0.325 0.729 1.105 0.54 -0.32 -0.159 0.433 U36922_at 0.77 287s S phase "Human fork head domain protein (FKHR) mRNA, 3' end. /gb=U36922 /ntype=RNA" 0.087 0.603 1.199 0.169 -0.482 -1.946 -0.509 -0.103 0.413 1.686 0.358 -1.079 -0.211 U37426_at 0.75 1m M phase KNSL1; kinesin-like 1 -0.525 -0.648 0.182 -0.492 0.717 -0.344 -0.591 -0.854 -1.445 -0.689 -0.163 0.807 0.232 U38964_at 0.58 175g2 G2 phase PMS2L8; postmeiotic segregation increased 2-like 8 -1.887 0.295 -0.239 0.016 -0.035 1.106 -1.583 -0.467 0.65 1.106 1.005 -0.163 0.016 U40038_at 0.65 325s S phase "GNAQ; guanine nucleotide binding protein (G protein), q polypeptide" -2.116 -0.116 0.248 -0.616 0.567 -0.979 -2.207 0.476 0.385 1.704 0.704 -1.025 -0.479 U40343_at 0.91 1m M phase "CDKN2D; cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)" -0.437 -0.284 0.957 1.747 1.473 0.485 -1.007 -1.337 -0.92 -0.7 0.068 0.287 0.079 U40462_at 0.69 6m M phase "ZNFN1A1; zinc finger protein, subfamily 1A, 1 (Ikaros)" 1.32 0.64 -0.555 -1.181 -0.041 0.604 1.467 0.824 0.493 -0.408 0.199 0.217 0.677 U43916_at 0.66 175g2 G2 phase EMP1; epithelial membrane protein 1 -0.457 -0.219 0.407 1.4 1.301 0.377 0.298 0.04 -0.05 0.516 0.775 -0.179 -0.417 U44429_at 0.62 2g2 G2 phase TPD52L1; tumor protein D52-like 1 -1.537 1.904 -0.022 -0.527 -0.243 -0.685 -0.842 0.105 0.231 0.799 -1.221 -0.905 0.01 U45880_at 0.8 325s S phase API3; apoptosis inhibitor 3 -1.893 -1.475 0.325 -0.621 0.979 -0.912 -2.402 0.179 -0.203 0.761 0.27 -0.385 0.379 U45983_at 0.68 107m M phase CCR8; chemokine (C-C motif) receptor 8 -2.054 0.299 0.357 -0.084 1.387 0.711 0.828 0.505 -0.055 -1.172 -0.437 0.328 0.21 U46023_at 0.54 1m M phase CSORF6; chromosome X open reading frame 6 0.148 -0.652 0.348 0.481 0.132 -0.885 0.414 -2.152 -1.252 -0.685 0.748 0.515 -0.069 U46751_at 0.74 368lg1 G1 phase SQSTM1; sequestosome 1 0.858 -0.072 -0.023 -1.382 -0.927 -1.07 0.531 0.401 0.48 0.583 0.482 -0.191 -0.817 U47077_at 0.92 287s S phase "PRKDC; protein kinase, DNA-activated, catalytic polypeptide" -0.257 -0.376 0.983 -0.73 -1.144 -1.242 -2.305 0.117 0.216 1.83 -0.967 -0.671 -0.356 U47105_at 0.69 53m M phase "Human H105e3 mRNA, complete cds" -0.084 -1.326 -1.163 0.357 1.448 1.367 2.005 -0.223 -0.095 -1.871 0.346 1.239 0.044 U47414_at 0.86 1m M phase CCNG2; cyclin G2 -1.529 -0.465 0.079 0.926 0.361 -0.596 -1.529 -0.661 -1.878 -0.269 0.318 -0.378 0.361 U48213_at 0.68 53m M phase DBP1; D site of albumin promoter (albumin D-box) binding protein -0.839 -0.624 0.273 -0.365 1.73 0.635 0.505 0.506 1.161 -1.356 -0.581 0.833 0.885 U48707_at 0.56 6m M phase "PPP1R1A; protein phosphatase 1, regulatory (inhibitor) subunit 1A " 1.496 0.833 -0.214 -1.056 -0.214 1.42 1.496 0.297 0.629 0.271 -0.75 0.961 0.807 U48861_at 0.57 201g2 G2 phase "CHRNB4; cholinergic receptor, nicotinic, beta polypeptide 4 " 1.245 -0.024 0.616 1.978 -0.85 -0.076 -0.179 -0.519 1.008 1.163 0.864 0.616 0.131 U52828_at 0.7 107m M phase "CTNND2; catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)" -0.095 -0.931 0.014 -0.284 1.227 1.524 0.499 -0.392 0.337 -1.605 -1.497 -0.553 -0.418 U53204_at 0.91 175g2 G2 phase "PLEC1; plectin 1, intermediate filament binding protein, 500kD" -0.071 -0.603 0.646 0.859 0.919 0.682 -0.335 -0.499 0.525 1.197 0.936 0.866 0.312 U53445_at 0.62 254s S phase DOC1; downregulated in ovarian cancer 1 0.302 1.824 0.856 -0.701 -1.003 -0.68 -0.553 -0.385 0.169 -0.175 0.429 -0.392 -0.203 U53446_at 0.96 201g2 G2 phase DAB2; disabled (Drosophila) homolog 2 (mitogen-responsive phosphoprotein) 1.998 0.237 0.592 0.198 0.214 -0.212 -1.865 -1.595 -0.351 -0.428 0.144 -0.011 -0.559 U54804_at 0.84 107m M phase HAS2; hyaluron synthase -1.151 -0.576 -0.473 0.114 1.157 0.012 -0.13 -0.123 -0.741 -1.19 -0.96 -0.667 -0.806 U55206_at 0.69 107m M phase "GGH; gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)" -0.722 -0.174 -1.063 -0.048 0.223 -0.491 0.375 0.003 -0.781 -0.926 -0.902 -0.495 -0.561 U56816_at 0.78 201g2 G2 phase PKMYT1; membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase 0.75 0.361 1.505 0.058 -0.34 -0.373 -1.739 -0.504 0.257 0.667 1.071 0.002 -0.314 U58090_at 0.81 201g2 G2 phase CUL4A; cullin 4A 0.553 0.209 0.263 0.294 0.312 0.133 -0.082 -0.203 0.289 0.491 0.67 0.186 0.227 U59321_at 0.6 201g2 G2 phase DDX17; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 17 (72kD) 1.195 0.322 -0.393 1.139 0.345 -0.62 -0.983 -1.062 -0.484 1.399 -0.313 -0.756 -0.359 U59752_at 0.84 201g2 G2 phase "PSCD2; pleckstrin homology, Sec7 and coiled/coil domains 2 (cytohesin-2)" 1.252 0.628 0.928 0.64 0.844 0.322 -1.436 -0.992 -0.836 1.228 1.276 0.04 -0.026 U63295_at 0.6 325s S phase SIAH1; seven in absentia (Drosophila) homolog 1 -1.156 -0.327 0.932 0.133 1.054 0.103 -1.708 0.839 1.852 0.747 0.103 -0.542 -0.696 U63743_at 0.88 53m M phase KNSL6; kinesin-like 6 (mitotic centromere-associated kinesin) -0.258 -0.495 -0.045 0.507 2.015 1.633 -0.387 -1.087 -0.966 -0.29 0.036 0.338 1.267 U64197_at 0.43 325s S phase "SCYA20; small inducible cytokine subfamily A (Cys-Cys), member 20" 0.191 0.124 1.282 0.912 -1.555 -0.112 -1.152 0.174 0.963 -0.011 0.778 -0.749 0.862 U65416_rna1_at 0.91 325s S phase MICB; MHC class I polypeptide-related sequence B -1.263 -0.811 0.663 0.052 -0.283 -0.627 -1.028 -0.677 -0.668 0.153 -0.283 -0.091 -0.392 U67849_at 0.69 175g2 G2 phase "Human beta-galactoside alpha2,6-sialyltransferase (SIAT1) mRNA, exon W. /gb=U67849 /ntype=RNA" 1.396 -0.306 -0.233 0.598 0.608 1.764 -0.453 -0.874 -0.285 0.955 1.407 -0.043 0.209 U69263_at 0.5 175g2 G2 phase MATN2; matrilin 2 -1.544 0.053 1.319 0.738 0.261 1.07 0.364 -1.358 1.049 1.402 -0.217 -0.072 -0.051 U72066_at 0.65 287s S phase RBBP8; retinoblastoma-binding protein 8 1.043 1.108 0.258 -0.735 -1.234 -1.175 -1.775 -0.646 0.413 0.246 -0.402 -0.437 -0.521 U72206_at 0.93 201g2 G2 phase ARHGEF2; rho/rac guanine nucleotide exchange factor (GEF) 2 1.253 0.187 0.334 1.317 0.182 0.524 -1.731 -1.193 -0.132 -0.361 1.439 0.202 0.011 U73379_at 0.84 1m M phase UBCH10; ubiquitin carrier protein E2-C -0.375 -0.738 0.202 1.076 1.722 1.502 -1.151 -1.734 -1.189 -0.519 0.86 0.544 0.273 U73737_at 0.73 368lg1 G1 phase MSH6; mutS (E. coli) homolog 6 -1.388 -0.681 -0.35 -0.907 -0.907 -0.757 -0.997 0.402 0.778 1.139 -0.817 -0.215 -0.215 U74612_at 0.71 53m M phase FOXM1; forkhead box M1 -0.066 -0.229 -0.604 1.606 1.557 0.694 0.314 -0.555 -1.348 -1.446 0.276 0.167 0.52 U75679_at 0.86 381lg1 G1 phase "HBP; Hairpin binding protein, histone" -0.695 -0.384 -0.552 -1.404 -1.012 -0.72 0.015 0.339 0.127 -0.284 -1 -0.589 -0.589 U76764_at 0.84 53m M phase CD97; CD97 antigen -1.424 -1.455 -0.221 0.983 1.74 1.532 0.799 0.452 -0.886 -0.422 -0.599 0.177 -0.062 U78722_at 0.91 6m M phase ZNF165; zinc finger protein 165 1.847 0.58 -0.492 -1.126 0.337 1.165 -0.102 1.36 -0.395 -1.759 -1.515 0.629 0.044 U79248_at 0.64 2g2 G2 phase Human clone 23826 mRNA sequence -1.238 0.421 0.213 0.124 -0.616 -0.231 -1.297 -0.142 0.154 0.006 -0.528 -0.172 -0.557 U79295_at 0.8 6m M phase Human clone 23961 mRNA sequence 2.044 -0.578 -0.751 0.463 0.311 -0.036 1.524 0.788 -0.275 -1.25 -1.076 -0.903 0.419 U80017_rna2_at 0.68 107m M phase NAIP; neuronal apoptosis inhibitory protein -0.318 -1.054 0.453 1.435 0.348 1.049 1.435 0.488 0.313 -0.739 0.699 0.313 0.348 U81001_at 0.69 2g2 G2 phase "Human SNRPN mRNA, 3' UTR, partial sequence " -1.035 0.324 0.682 0.706 -0.487 -0.487 -0.892 -0.535 0.634 1.445 0.324 -0.964 0.491 U81375_at 0.94 201g2 G2 phase "SLC29A1; solute carrier family 29 (nucleoside transporters), member 1" 1.582 0.582 0.795 0.332 0.119 0.489 -1.53 -1.91 0.462 -0.048 0.832 -0.02 -1.039 U81556_at 0.91 325s S phase OS4; conserved gene amplified in osteosarcoma -0.493 -0.182 0.615 -0.026 0.073 -0.313 -1.041 -0.47 0.027 0.154 0.144 0.148 0.366 U90426_at 0.63 1m M phase "DDXL; nuclear RNA helicase, DECD variant of DEAD box family" -0.871 0.122 0.533 0.878 0.713 1.027 0.199 -1.412 0.338 -0.028 0.271 0.482 0.014 U90551_at 0.52 368lg1 G1 phase "H2AFL; H2A histone family, member L" -1.426 0.374 -0.17 -1.29 -0.747 -1.494 -0.815 0 0.272 -0.068 -0.272 -0.509 0.883 U92459_at 0.46 6m M phase "Human metabotropic glutamate receptor 8 mRNA, complete cds" 0.278 0.109 -0.692 -1.914 0.657 0.025 1.289 -0.102 0.067 -1.324 0.446 0.742 0.025 U96114_at 0.66 287s S phase WWP2; Nedd-4-like ubiquitin-protein ligase 0.156 0.156 0.903 0.035 -0.43 -0.319 -0.127 -0.41 1.207 2.519 1.398 0.53 -0.188 X00588_at 0.7 2g2 G2 phase EGFR; epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) -2.702 0.858 0.342 0.545 0.711 -0.194 -1.743 -0.71 0.323 0.212 -0.323 -0.341 -1.614 X03473_at 0.73 325s S phase "H1F0; H1 histone family, member 0 " -1.868 -0.88 0.888 1.72 1.294 -0.423 -0.37 -0.849 -0.11 0.94 1.419 0.056 -0.423 X03934_at 0.63 325s S phase "CD3D; CD3D antigen, delta polypeptide (TiT3 complex)" -1.903 0.221 1.463 0.401 0.531 0.825 -0.792 -0.613 0.711 0.286 -0.368 0.009 -1.054 X04602_at 0.96 254s S phase "IL6; interleukin 6 (interferon, beta 2)" -0.432 0.685 0.556 0.575 -0.298 -0.414 -0.552 -0.543 -0.497 -0.395 -0.644 -0.474 -0.617 X05360_at 0.82 1m M phase "CDC2; cell division cycle 2, G1 to S and G2 to M" -0.324 -0.346 0.27 0.415 0.773 0.426 -1.935 -1.555 -1.655 -0.301 0.303 0.236 -0.615 X06256_at 0.9 175g2 G2 phase "ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide)" 0.5 -0.385 0.47 1.059 0.792 1.085 -0.368 -0.004 -0.188 1.328 1.621 0.109 -0.589 X07315_at 0.53 287s S phase PP15; nuclear transport factor 2 (placental protein 15) 0.726 0.743 -0.356 -0.88 -0.224 -0.478 -1.699 -0.519 1.365 0.464 -0.306 -0.421 -0.331 X07496_at 0.53 107m M phase APOA1; apolipoprotein A-I -2.043 -0.15 0.501 0.531 0.737 -0.653 1.004 0.456 -0.387 -0.771 -0.609 0.057 1.004 X12458_rna1_at 0.67 325s S phase Human P3 gene -0.407 -0.194 1.532 1.696 1.074 0.011 -0.848 -0.374 0.248 0.469 -0.922 -0.374 -0.202 X12492_at 0.52 6m M phase NFIC; nuclear factor I/C (CCAAT-binding transcription factor) 1.427 0.066 0.612 -1.226 -1.047 1.407 0.652 0.672 0.096 -0.938 0.195 0.662 0.94 X14684_at 0.72 287s S phase SSB; Sjogren syndrome antigen B (autoantigen La) 1.163 -0.202 -0.179 -0.712 -1.818 -0.775 -0.83 -0.1 -0.532 2.12 0.112 0.026 -0.579 X14850_at 0.74 53m M phase "H2AFX; H2A histone family, member X " -0.884 -0.857 0.054 0.442 0.479 0.188 0.431 -1.023 -1.308 -0.207 0.357 -0.194 0.467 X15880_at 0.9 107m M phase "COL6A1; collagen, type VI, alpha 1" -0.872 -0.511 -0.248 0.028 1.065 0.212 -0.115 0.569 -0.806 -2.179 -0.787 -0.009 -0.487 X16504_at 0.9 6m M phase "ENO3; enolase 3, (beta, muscle) " 0.944 0.497 -0.809 -0.715 0.757 0.31 0.608 1.018 -0.622 -1.442 -0.175 0.329 0.72 X17042_at 0.84 107m M phase PRG1; proteoglycan core protein -0.454 -0.432 -0.609 -0.046 -0.1 -0.385 0.147 -0.038 -0.547 -1.318 -1.056 -0.431 -0.532 X17254_at 0.91 325s S phase GATA1; GATA-binding protein 1 (globin transcription factor 1) -0.812 -1.402 1.122 0.367 0.427 -0.299 -2.203 -0.752 -0.375 -0.51 0.246 -0.737 -0.495 X51345_at 0.72 254s S phase JUNB; jun B proto-oncogene -0.199 2.95 0.342 -0.187 -0.47 -0.462 -0.271 -0.364 -0.442 0.269 -0.279 -0.476 -0.376 X51417_at 0.68 107m M phase ESRRB; -1.536 -0.114 0.238 0.222 0.333 0.781 1.148 1.468 -0.434 -0.993 -1.408 1.292 1.068 X51688_at 0.68 1m M phase CCNA2; cyclin A2 -0.624 -0.315 0.427 0.15 0.838 1.93 -1.047 -1.217 -0.435 -0.207 1.128 0.235 0.017 X52022_at 0.64 107m M phase "COL6A3; collagen, type VI, alpha 3" -0.941 -0.869 0.534 1.243 1.027 1.292 0.301 0.226 -0.15 0.238 0.077 -0.468 -0.494 X52142_at 0.79 254s S phase CTPS; CTP synthase 0.582 1.301 0.859 2.413 0.989 -0.419 -0.419 -0.315 -0.175 -0.256 -0.282 -0.471 -0.871 X52213_at 0.67 107m M phase LTK; leukocyte tyrosine kinase -1.554 -0.249 -0.415 0.037 0.357 0.5 0.773 0.167 -0.451 -1.08 -0.261 -1.044 0.488 X52282_at 0.6 6m M phase NPR3; natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) 0.051 -0.81 0.339 -0.906 0.084 0.657 0.944 1.837 -0.109 -0.586 -0.937 -0.459 0.02 X52541_at 0.63 254s S phase EGR1; early growth response 1 0.047 2.912 0.017 -0.314 -0.878 -0.735 -0.464 -0.412 -0.322 0.573 -0.014 -0.209 -0.412 X53416_at 0.74 53m M phase "FLNA; filamin A, alpha (actin-binding protein-280)" 0.101 -0.109 0.506 1.207 0.967 1.319 0.315 -0.178 -0.38 -0.922 0.873 0.701 0.194 X53586_rna1_at 0.96 107m M phase "ITGA6; integrin, alpha 6" -0.852 -0.942 -0.581 1.276 1.158 1.113 0.194 1.005 -0.077 -1.879 -0.663 -0.149 -0.573 X54489_rna1_at 0.76 325s S phase "GRO1; GRO1 oncogene (melanoma growth stimulating activity, alpha)" -1.106 -0.496 0.765 1.037 0.401 -0.392 -0.613 -1.094 -0.717 0.582 -0.132 -0.249 -0.379 X54816_at 0.6 254s S phase AMBP; alpha-1-microglobulin/bikunin precursor 0.741 0.209 1.111 1.157 0.024 -0.324 -0.509 0.393 0.162 0.833 -1.342 -1.18 -0.185 X54941_at 0.89 1m M phase CKS1; CDC28 protein kinase 1 -0.965 -0.672 0.633 -0.306 0.388 0.051 -1.369 -1.48 -0.758 -1.013 -0.643 0.056 0.007 X54942_at 0.83 53m M phase CKS1; CDC28 protein kinase 2 -1.176 -1.37 0.145 -0.34 0.768 1.24 -0.901 -1.757 -0.993 -0.501 0.596 0.945 0.532 X55740_at 0.79 107m M phase NT5; 5' nucleotidase (CD73) -1.699 -0.875 -0.675 0.023 1.077 0.513 0.586 0.966 0.429 -1.852 -0.211 -0.526 -0.239 X55954_at 0.68 368lg1 G1 phase RPL23; ribosomal protein L23 1.692 -0.039 0.778 -0.241 -0.579 -0.124 0.599 0.437 0.682 1.027 1.051 0.693 0.173 X57809_at 0.66 381lg1 G1 phase IGL@; immunoglobulin lambda locus 0.117 0.868 0.211 -0.666 -1.026 0.023 0.461 1.229 0.008 0.336 -0.838 -0.682 0.07 X58377_at 0.93 254s S phase IL11; interleukin 11 -0.852 0.695 1.214 0.473 -0.16 -0.315 -0.513 -0.481 -0.308 -0.167 -0.668 -0.721 -0.658 X59373_at 0.69 175g2 G2 phase HOXD10; homeo box D10 0.081 0.021 -0.805 0.096 0.591 0.366 -0.37 -0.956 0.231 2.242 0.786 0.876 0.006 X59798_at 0.49 107m M phase CCND1; cyclin D1 (PRAD1: parathyroid adenomatosis 1) -0.879 -0.862 -0.598 -0.026 1.062 1.175 2.214 1.182 -0.043 0.242 0.265 0.348 -0.615 X60188_at 0.72 6m M phase MAPK3; mitogen-activated protein kinase 3 1.677 -0.767 -0.135 -0.3 0.332 0.35 0.103 -0.016 -1.06 -1.654 -0.026 -0.154 0.313 X60486_at 0.76 2g2 G2 phase "H4FG; H4 histone family, member G" -0.209 0.683 1.704 0.892 -0.966 -1.319 -0.908 -0.264 0.535 1.053 0.203 -0.119 -0.815 X62048_at 0.95 325s S phase WEE1; wee1+ (S. pombe) homolog -1.414 -0.431 0.704 -0.103 -0.002 -0.507 -1.868 -0.608 -0.734 0.401 0.3 -0.179 -0.305 X62153_at 0.94 368lg1 G1 phase MCM3; minichromosome maintenance deficient (S. cerevisiae) 3 -0.13 0.011 0.465 -1.607 -1.494 -1.039 -0.21 0.712 1.548 1.607 0.137 0.158 0.318 X62691_at 0.73 368lg1 G1 phase H.sapiens mRNA for ribosomal protein (homologuous to yeast S24) -0.391 0.413 0.44 -0.386 -0.86 -0.386 -0.852 0.376 1.397 1.558 0.972 1.139 0.216 X63468_at 0.61 368lg1 G1 phase "GTF2E1; general transcription factor IIE, polypeptide 1 (alpha subunit, 56kD)" -0.156 -0.834 1.039 0.522 -0.931 -0.059 0.296 0.135 0.781 1.974 0.587 -0.64 -0.027 X65550_at 0.69 53m M phase MKI67; antigen identified by monoclonal antibody Ki-67 -1.09 -0.934 -0.503 -0.563 0.403 0.046 -0.169 -0.578 -0.756 -1.268 -0.682 -0.066 1.947 X66087_at 0.94 201g2 G2 phase MYBL1; v-myb avian myeloblastosis viral oncogene homolog-like 1 1.285 0.368 1.187 0.92 0.042 -0.807 -1.773 -1.408 -0.649 0.042 0.891 0.032 -0.383 X66364_at 0.6 201g2 G2 phase CDK5; cyclin-dependent kinase 5 1.858 0.867 0.006 0.96 -0.168 0.266 -0.235 -0.242 0.236 1.66 1.028 -0.279 0.453 X66534_at 0.57 53m M phase "GUCY1A3; guanylate cyclase 1, soluble, alpha 3" 0.056 -1.7 -0.03 -0.244 0.571 1.085 2.199 0.014 -0.201 -0.715 -0.244 0.1 0.442 X67155_at 0.95 1m M phase KNSL5; kinesin-like 5 (mitotic kinesin-like protein 1) -0.839 -0.763 1.128 0.315 0.766 -0.193 -1.349 -1.618 -1.438 -0.442 -0.439 -0.262 0.428 X68836_at 0.56 201g2 G2 phase "MAT2A; methionine adenosyltransferase II, alpha" -0.214 0.911 0.643 0.465 0.483 1.376 -1.143 -0.947 -0.661 0.786 1.036 -0.679 0.018 X69111_at 0.92 368lg1 G1 phase "ID3; inhibitor of DNA binding 3, dominant negative helix-loop-helix protein" 0.437 -0.846 -0.763 -1.487 -1.116 -0.396 0.68 0.5 1.278 1.06 0.156 -0.25 0.607 X70476_at 0.91 368lg1 G1 phase "COPB2; coatomer protein complex, subunit beta 2 (beta prime) " 0.094 -1.223 -0.514 -1.028 -1.752 -0.782 0.518 0.567 0.193 1.76 0.359 -0.245 0.143 X70991_at 0.68 287s S phase NAB2; NGFI-A binding protein 2 (ERG1 binding protein 2) -0.265 -0.465 1.898 -0.266 0.072 -0.863 -0.046 -0.485 0.498 1.864 -0.327 -1.186 -0.492 X72632_at 0.76 381lg1 G1 phase 0.028 -0.556 -0.124 -0.649 -1.478 0.425 0.962 1.324 1.102 0.425 -0.719 -0.696 0.11 X74331_at 0.68 368lg1 G1 phase "PRIM2A; primase, polypeptide 2A (58kD)" -0.277 -0.15 0.392 -0.622 -0.376 -0.337 -1.006 -0.061 1.307 0.903 0.609 0.284 -0.052 X75958_at 0.66 6m M phase "NTRK2; neurotrophic tyrosine kinase, receptor, type 2" 1.019 0.525 -0.5 -1.83 -0.121 1.171 0.791 0.336 -0.387 -0.5 -0.956 1.095 0.184 X76228_at 0.83 107m M phase "ATP6E; ATPase, H+ transporting, lysosomal (vacuolar proton pump) 31kD; Vacuolar proton-ATPase, subunit E; V-ATPase, subunit E" -0.969 -0.428 -0.335 1.756 0.974 1.008 1.114 0.62 -0.315 -0.595 0.173 0.621 0.153 X76942_at 0.59 287s S phase "GOLGA4; golgi autoantigen, golgin subfamily a, 4" 1.496 0.455 -0.156 0.689 0.06 0.293 -1.233 -0.767 0.006 2.233 -0.515 -0.947 -0.677 X77753_at 0.73 287s S phase "M1S1; membrane component, chromosome 1, surface marker 1 (40kD glycoprotein, identified by monoclonal antibody GA733)" 0.485 0.742 0.967 0.838 -0.606 -1.473 0.293 0.518 0.036 1.962 -1.377 -0.767 0.132 X78136_at 0.68 107m M phase PCBP2; poly(rC)-binding protein 2 0.09 0.09 0.739 1.16 0.08 1.035 0.547 0.184 -0.043 -1.545 0.595 0.066 0.188 X79439_at 0.55 107m M phase H.sapiens Notch 3 DNA sequence. /gb=X79439 /ntype=DNA /annot=CDS -0.123 -0.202 0.448 -0.508 0.647 0.587 2.291 0.853 -1.422 -1.9 -0.494 0.315 1.462 X79683_at 0.7 325s S phase "LAMB2; laminin, beta 2 (laminin S)" -1.16 0.639 0.782 0.654 0.419 -0.382 -1.251 -0.986 1.062 -0.042 0.299 0.276 0.495 X80230_at 0.64 201g2 G2 phase CDK9; cyclin-dependent kinase 9 (CDC2-related kinase) 1.08 -0.021 1.556 0.93 -0.596 -0.446 -1.022 -1.072 0.58 0.279 0.08 -1.172 0.83 X80692_at 0.85 107m M phase MAPK6; mitogen-activated protein kinase 6 -0.552 0.061 -0.594 1.287 0.296 0.162 -0.334 0.648 -0.913 -1.324 -1.383 0.212 -0.518 X81479_at 0.66 287s S phase "EMR1; egf-like module containing, mucin-like, hormone receptor-like sequence 1" -0.212 -0.213 0.916 -0.767 -0.427 0.057 -0.606 -0.105 0.021 0.898 -1.072 -1.036 -0.785 X81788_at 0.62 287s S phase ICT1; immature colon carcinoma transcript 1 0.649 -0.058 -0.553 -0.524 -1.217 -0.171 -0.877 -0.99 0.423 1.666 0.295 0.479 0.126 X81851_at 0.62 107m M phase IL4; interleukin 4 -0.356 -0.896 -0.531 -0.147 0.428 -0.635 -0.217 0.602 0.585 -2.133 -1.82 0.532 0.08 X82877_at 0.53 107m M phase "RSC1A1; regulatory solute carrier protein, family 1, member 1" -0.027 -0.064 -0.192 0.395 0.322 1.018 0.303 -0.027 -0.779 -0.247 0.12 -0.724 0.45 X82895_at 0.54 201g2 G2 phase "MPP2; membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)" 2.024 0.609 -0.074 0.533 -0.487 0.533 -0.183 -0.445 0.39 1.855 1.266 0.027 0.727 X84213_at 0.54 175g2 G2 phase BAK1; BCL2-antagonist/killer 1 1.12 0.11 0.568 1.268 0.925 2.19 -0.132 -0.341 -0.422 0.729 0.178 -0.362 0.151 X85137_at 0.75 53m M phase KNSL1; kinesin-like 1 -0.986 -1.172 0.581 -0.566 0.348 0.795 -0.781 -0.846 -0.818 -0.575 0.618 0.982 0.861 X87613_at 0.73 53m M phase H.sapiens mRNA for skeletal muscle abundant protein 0.002 -0.447 -0.128 -0.188 0.155 0.223 -0.409 -0.432 -0.31 -0.348 -0.135 0.048 0.033 X89398_cds2_at 0.92 381lg1 G1 phase UNG; uracil-DNA glycosylase 0.053 -0.555 -0.096 -1.445 -0.905 -1.229 -0.676 1.887 1.226 -0.055 -0.649 0.242 -0.77 X89399_at 0.75 175g2 G2 phase "RASA3; RAS p21 protein activator (GTPase activating protein) 3 (Ins(1,3,4,5)P4-binding protein)" -0.961 -0.431 0.058 -0.615 0.424 -0.024 -1.164 -0.655 -0.268 0.628 0.119 -0.452 -0.92 X89750_at 0.73 2g2 G2 phase TGIF; TG-interacting factor (TALE family homeobox) -0.86 0.233 0.882 2.15 0.095 -0.569 -0.918 -1.166 -1.064 0.087 0.846 -0.452 -0.387 X89985_at 0.45 2g2 G2 phase BCL7B; B-cell CLL/lymphoma 7B -1.247 1.141 -0.047 -0.205 -0.74 -0.467 -0.944 -1.148 0.96 0.221 0.529 0.669 0.232 X90763_at 0.39 6m M phase "KRTHA5; keratin, hair, acidic, 5" 2.183 0.366 0.111 0.202 -0.909 1.642 1.582 0.757 0.157 0.381 0.967 0.142 0.202 X90976_at 0.71 107m M phase RUNX1; runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) -1.887 0.331 -0.394 -0.211 1.449 0.654 1.309 0.524 0.156 -1.695 -1.128 0.419 0.279 X92720_at 0.89 201g2 G2 phase PCK2; phosphoenolpyruvate carboxykinase 2 (mitochondrial) 1.629 -0.077 0.812 1.185 0.559 0.529 -1.097 -1.552 -0.017 -1.117 0.61 0.317 -0.451 X96506_at 0.56 175g2 G2 phase DRAP1; DR1-associated protein 1 (negative cofactor 2 alpha) 0.507 -0.182 -0.143 1.106 1.42 0.273 0.076 -0.766 -0.281 0.519 0.27 -0.063 0.339 X96753_at 0.8 1m M phase CSPG4; chondroitin sulfate proteoglycan 4 (melanoma-associated) 0.352 -0.266 1.576 1.566 1.327 1.078 -1.014 -0.992 -1.112 0.026 -0.44 0.233 -0.104 X98534_at 0.94 107m M phase VASP; vasodilator-stimulated phosphoprotein -0.719 -0.748 -0.03 1.106 0.766 0.747 0.048 0.466 -1.122 -1.039 -0.821 -0.301 -0.059 X99585_at 0.63 287s S phase "SMT3H2; SMT3 (suppressor of mif two 3, yeast) homolog 2" -0.292 -0.27 0.602 -0.632 -1.232 -0.989 -1.379 -1.362 0.636 0.172 -0.451 0.054 -0.53 X99894_at 0.7 201g2 G2 phase "IPF1; insulin promoter factor 1, homeodomain transcription factor" 1.979 -1.12 -0.136 1.394 0.649 1.327 -1.719 -0.296 -0.508 0.596 1.673 -0.07 -0.123 Y00764_at 0.66 287s S phase UQCRH; ubiquinol-cytochrome c reductase hinge protein -0.9 -0.292 0.141 -0.668 -1.09 -0.678 -1.142 -0.969 0.445 0.311 -0.701 0.196 -0.233 Y00971_at 0.43 381lg1 G1 phase PRPS2; phosphoribosyl pyrophosphate synthetase 2 -0.329 0.743 -0.042 -0.643 -1.296 -1.531 -0.747 0.847 -0.512 -0.381 0.089 -1.087 0.22 Y07707_at 0.63 381lg1 G1 phase NRF; transcription factor NRF -0.894 0.2 -0.348 -1.311 -0.295 -0.478 0.512 0.903 -0.009 0.981 -1.806 -0.296 -0.452 Y08613_at 0.5 1m M phase NUP88; nucleoporin 88kD 1.463 0.73 0.57 1.532 0.478 -0.05 0.042 -1.195 -1.149 -0.599 -0.347 -0.141 1.715 Y08766_at 0.64 1m M phase ZNF162; zinc finger protein 162 -0.07 -0.397 0.499 -0.345 0.243 0.7 -0.247 -1.134 -0.247 -0.853 0.49 0.42 0.802 Y10514_at 0.61 53m M phase -1.711 -0.456 0.065 -0.059 0.585 0.187 0.125 1.074 -1.834 -1.589 0.677 0.371 1.013 Y13620_at 0.56 325s S phase BCL9; B-cell CLL/lymphoma 9 -0.514 -1.365 -0.296 -0.158 0.1 -0.435 -1.622 -0.375 0.971 0.516 0.575 -0.712 0.555 Z21707_at 0.74 2g2 G2 phase ZNF197; zinc finger protein 197 -1.432 0.438 0.438 0.72 1.002 -0.612 -1.227 -0.356 0.694 0.566 0.413 -0.869 0.336 Z22535_at 0.71 368lg1 G1 phase "BMPR1A; bone morphogenetic protein receptor, type IA " -1.72 0.469 -0.271 -1.129 -1.454 -1.247 -0.182 1.534 0.735 2.007 -1.04 0.232 0.38 Z24725_at 0.72 254s S phase MIG2; mitogen inducible 2 -0.474 0.062 1.072 1.897 0.323 0.161 -1.068 -0.441 -0.578 0.688 -1.137 -0.708 -0.903 Z29066_at 0.85 53m M phase NEK2; NIMA (never in mitosis gene a)-related kinase 2 -0.925 -0.944 -0.078 -0.73 0.314 0.798 -0.776 -0.683 -1.074 -1.558 -0.459 0.295 0.64 Z29067_at 0.72 107m M phase NEK3; NIMA (never in mitosis gene a)-related kinase 3 -0.653 -0.991 0.463 1.544 0.631 0.395 0.766 0.057 -0.653 -0.518 -0.079 0.462 0.226 Z34918_at 0.79 325s S phase "EIF4G3; eukaryotic translation initiation factor 4 gamma, 3 " -1.05 -0.084 0.86 0.231 -0.084 0.388 -1.589 -0.017 0.815 0.837 0.051 0.231 0.051 Z35278_at 0.62 287s S phase RUNX3; runt-related transcription factor 3 0.023 0.2 -0.199 0.711 0.445 -0.022 -0.465 0.023 -0.177 1.975 0.289 0.711 0.2 Z36714_at 0.86 53m M phase CCNF; cyclin F -0.557 -1.518 0.09 1.29 2.059 1.312 0.259 -0.741 -0.358 -0.02 0.87 0.171 0.494 Z46261_at 0.5 6m M phase "ESTs, Moderately similar to neuronal thread protein AD7c-NTP [H.sapiens] " 0.74 1.456 -0.095 -0.477 0.048 -0.668 2.124 0.359 0.979 -1.646 -1.384 -0.119 -0.429 Z46629_at 0.75 2g2 G2 phase "SOX9; SRY (sex-determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)" -1.191 1.803 0.59 1.264 1.183 0.536 -1.73 0.05 0.239 0.697 -0.193 -0.706 -0.813 Z49989_at 0.86 53m M phase SMTN; smoothelin -1.373 -0.852 -0.14 0.877 1.443 2.104 -0.072 -0.148 -0.526 -0.801 -0.152 0.045 -0.262 Z68228_at 0.63 53m M phase JUP; junction plakoglobin -1.586 -0.695 -0.61 0.009 1.529 -0.367 -0.704 0.553 -0.676 -0.554 -1.389 0.516 -0.039 Z84722_at 0.65 6m M phase "Human DNA sequence from cosmid GG4 from a contig from the tip of the short arm of chromosome 16, spanning 2Mb of 16p13.3" 0.239 0.239 -0.111 -0.349 0.552 0.352 0.639 0.577 0.739 -1.412 -0.149 0.352 0.752 Z97054_xpt2_at 0.61 325s S phase UREB1; upstream regulatory element binding protein 1 -1.353 -0.222 0.421 -0.027 1.105 -0.303 -1.313 -0.089 1.727 0.483 0.024 0.391 0.412